Iatrogenic hyperchloremia: An overview in hospitalized patients for pharmacists
American Journal of Health-System Pharmacy · 19.08.2024 · 81 (17) · e462-e470
DOI: 10.1093/ajhp/zxae086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 26.03.2024. Verfasst von Amoreena Most und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Iatrogenic Disease, Pharmacists, Fluid Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Purpose
The purpose of this therapeutic update is to provide pharmacists with a general overview of the pathophysiology of hyperchloremia and describe strategies to help prevent development of this electrolyte abnormality in hospitalized patients. Summary Hyperchloremia is an electrolyte abnormality associated with an increased incidence of acute kidney injury and metabolic acidosis. Intravenous (IV) fluids utilized for volume resuscitation, medication diluents, and total parental nutrition all may contribute to the development of hyperchloremia. Current evidence suggests that administration of balanced crystalloids for either fluid resuscitation or maintenance fluids may impact serum chloride levels and patient outcomes. In multiple randomized controlled trials, administering balanced crystalloids for fluid resuscitation in critically ill patient populations did not decrease mortality. However, further analyses of subpopulations within these trials have demonstrated that patients with sepsis may benefit from receiving balanced crystalloids for initial fluid resuscitation. Results from several small studies suggest that altering the composition of these IV fluids may help prevent development of hyperchloremia.
Conclusion
Management of hyperchloremia is preventative in nature and can be mitigated through management of resuscitation fluids, medication diluents, and total parenteral nutrition. Inpatient pharmacists should be aware of the potential risk of fluid-associated hyperchloremia and assist with optimal fluid management to prevent and manage hyperchloremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, USA.
Zitieren
APA
Most, A., Nordbeck, S., & Farina, N. (2024). Iatrogenic hyperchloremia: An overview in hospitalized patients for pharmacists. American Journal of Health-System Pharmacy, 81(17), e462-e470. https://doi.org/10.1093/ajhp/zxae086
Vancouver
Most A, Nordbeck S, Farina N. Iatrogenic hyperchloremia: An overview in hospitalized patients for pharmacists. American Journal of Health-System Pharmacy. 2024;81(17):e462-e470. doi:10.1093/ajhp/zxae086
BibTeX
@article{Most2024,
author = {Most, Amoreena and Nordbeck, Sarah and Farina, Nicholas},
title = {Iatrogenic hyperchloremia: An overview in hospitalized patients for pharmacists},
journal = {American Journal of Health-System Pharmacy},
year = {2024},
volume = {81},
number = {17},
pages = {e462--e470},
doi = {10.1093/ajhp/zxae086}
}
EUVIMED